Back to VRDN

Avoro Capital Advisors LLC → VRDN

Avoro Capital Advisors LLC VRDN Position History

Viridian Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$51.5M
Q3 2026
Peak value
$51.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$46.7M
Q4 2025$46.7M
Q1 2026$29.3M
Q2 2026$45.9M
Q3 2026$51.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$51.5M2.50M——
Q2 2026$45.9M2.50M——
Q1 2026$29.3M1.50M——
Q4 2025$46.7M1.50M——
Q4 2025$46.7M1.50M——

Other funds holding VRDN

Other Avoro Capital Advisors LLC positions

UTHR

UNITED THERAPEUTICS CORP

$1.6B
UTHR

UNITED THERAPEUTICS CORP

$1.5B
UTHR

UNITED THERAPEUTICS CORP

$1.5B
ASND

ASCENDIS PHARMA

$1.4B
UTHR

UNITED THERAPEUTICS CORP

$1.3B
UTHR

UNITED THERAPEUTICS CORP

$1.3B
ASND

ASCENDIS PHARMA

$1.2B
ASND

ASCENDIS PHARMA A/S

$1.2B